Literature DB >> 16980144

VEINES-QOL/Sym questionnaire was a reliable and valid disease-specific quality of life measure for deep venous thrombosis.

Susan R Kahn1, Donna L Lamping, Thierry Ducruet, Louise Arsenault, Marie José Miron, André Roussin, Sylvie Desmarais, France Joyal, Jeannine Kassis, Susan Solymoss, Louis Desjardins, Mira Johri, Ian Shrier.   

Abstract

OBJECTIVE: To assess the validity of VEINES-QOL/Sym, a patient-reported questionnaire to evaluate quality of life and symptoms in patients with deep venous thrombosis (DVT). STUDY DESIGN AND
SETTING: Psychometric study within the Venous Thrombosis Outcomes (VETO) Study, a prospective cohort study of long-term outcomes after DVT. A total of 359 English- and French-speaking patients with acute, objectively diagnosed DVT were recruited at seven hospitals in Quebec, Canada. The VEINES-QOL/Sym questionnaire, a 26-item patient-reported measure that generates separate summary scores for symptoms (VEINES-Sym) and quality of life (VEINES-QOL) was evaluated for acceptability, reliability, validity, and responsiveness in VETO Study subjects.
RESULTS: Standard psychometric tests confirmed the acceptability (missing data, item endorsement frequencies, floor and ceiling effects), reliability (internal consistency, item-total and inter-item correlations, test-retest), validity (content, construct, convergent, discriminant, known groups), and responsiveness to clinical change of the VEINES-QOL/Sym in patients with DVT.
CONCLUSION: The VEINES-QOL/Sym is a practical and scientifically sound patient-reported measure of outcomes that was developed using gold-standard methods. VEINES-QOL/Sym is valid and reliable for use as a measure of quality of life and symptoms in patients with acute DVT and provides a rigorous tool to allow more comprehensive evaluation of outcomes in clinical trials and epidemiological studies of patients with DVT.

Entities:  

Mesh:

Year:  2006        PMID: 16980144     DOI: 10.1016/j.jclinepi.2005.10.016

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  35 in total

1.  Six-month exercise training program to treat post-thrombotic syndrome: a randomized controlled two-centre trial.

Authors:  Susan R Kahn; Ian Shrier; Stan Shapiro; Adrielle H Houweling; Andrew M Hirsch; Robert D Reid; Clive Kearon; Khalil Rabhi; Marc A Rodger; Michael J Kovacs; David R Anderson; Philip S Wells
Journal:  CMAJ       Date:  2010-11-22       Impact factor: 8.262

2.  Endovascular therapy for advanced post-thrombotic syndrome: Proceedings from a multidisciplinary consensus panel.

Authors:  Suresh Vedantham; Susan R Kahn; Samuel Z Goldhaber; Anthony J Comerota; Sameer Parpia; Sreelatha Meleth; Diane Earp; Rick Williams; Akhilesh K Sista; William Marston; Suman Rathbun; Elizabeth A Magnuson; Mahmood K Razavi; Michael R Jaff; Clive Kearon
Journal:  Vasc Med       Date:  2016-05-30       Impact factor: 3.239

3.  PURLs: skip the compression stockings following DVT.

Authors:  Keri Bergeson; Shailendra Prasad; Janice Benson
Journal:  J Fam Pract       Date:  2014-07       Impact factor: 0.493

4.  Post-thrombotic syndrome is an independent determinant of health-related quality of life following both first proximal and distal deep vein thrombosis.

Authors:  Lara N Roberts; Raj K Patel; Nora Donaldson; Lynda Bonner; Roopen Arya
Journal:  Haematologica       Date:  2014-01-17       Impact factor: 9.941

5.  The VEINES-QOL/Sym questionnaire is a reliable and valid disease-specific quality of life measure for deep vein thrombosis in elderly patients.

Authors:  M Méan; A Limacher; S R Kahn; D Aujesky
Journal:  Qual Life Res       Date:  2014-05-04       Impact factor: 4.147

6.  Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis.

Authors:  Susan R Kahn; Jim A Julian; Clive Kearon; Chu-Shu Gu; David J Cohen; Elizabeth A Magnuson; Anthony J Comerota; Samuel Z Goldhaber; Michael R Jaff; Mahmood K Razavi; Andrei L Kindzelski; Joseph R Schneider; Paul Kim; Rabih Chaer; Akhilesh K Sista; Robert B McLafferty; John A Kaufman; Brandt C Wible; Morey Blinder; Suresh Vedantham
Journal:  J Vasc Surg Venous Lymphat Disord       Date:  2020-01

7.  Treatment-Related Outcomes in Paget-Schroetter Syndrome-A Cross-Sectional Investigation.

Authors:  Riten Kumar; Katherine Harsh; Surbhi Saini; Sarah H O'Brien; Joseph Stanek; Patrick Warren; Jean Giver; Michael R Go; Bryce A Kerlin
Journal:  J Pediatr       Date:  2018-12-07       Impact factor: 4.406

8.  Rationale and design of the ATTRACT Study: a multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis.

Authors:  Suresh Vedantham; Samuel Z Goldhaber; Susan R Kahn; Jim Julian; Elizabeth Magnuson; Michael R Jaff; Timothy P Murphy; David J Cohen; Anthony J Comerota; Heather L Gornik; Mahmood K Razavi; Lawrence Lewis; Clive Kearon
Journal:  Am Heart J       Date:  2013-03-05       Impact factor: 4.749

9.  The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodology.

Authors:  Marie Méan; Marc Righini; Kurt Jaeger; Hans-Jürg Beer; Beat Frauchiger; Joseph Osterwalder; Nils Kucher; Bernhard Lämmle; Jacques Cornuz; Anne Angelillo-Scherrer; Nicolas Rodondi; Andreas Limacher; Sven Trelle; Christian M Matter; Marc Husmann; Martin Banyai; Markus Aschwanden; Michael Egloff; Lucia Mazzolai; Olivier Hugli; Henri Bounameaux; Drahomir Aujesky
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

Review 10.  Incidence and cost burden of post-thrombotic syndrome.

Authors:  Aneel A Ashrani; John A Heit
Journal:  J Thromb Thrombolysis       Date:  2009-02-18       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.